0
0
NEW DELHI — In a move that could reshape the landscape of critical care and organ transplantation in India, the Supreme Court has directed the All India Institute of Medical Sciences (AIIMS) to form an expert committee to scrutinize the nation’s brain death certification protocols.
The judicial directive, issued on April 28, 2026, by a bench comprising Justices Vikram Nath and Sandeep Mehta, addresses growing concerns over the reliability and transparency of current medical procedures used to declare a person legally dead while their heart is still beating. The Court’s decision follows a petition highlighting alleged procedural lapses and advocating for the integration of more objective technological diagnostics.
The Heart of the Contention: The Apnea Test
At the center of this legal and medical inquiry is the apnea test. Currently, under the Transplantation of Human Organs and Tissues Act (THOTA), 1994, brain death is determined clinically. A patient must show no response to external stimuli and a total absence of brainstem reflexes. The apnea test is the final, mandatory step, where a patient is briefly removed from a ventilator to see if rising carbon dioxide levels in the blood trigger a spontaneous breath.
The petitioner, Kerala-based physician and activist Dr. S. Ganapathy, argued before the Court that the apnea test is “subjective and not foolproof.” His petition alleges that the test itself carries risks, potentially worsening brain injury by reducing blood flow or causing cardiac instability.
“There is a procedure in place. It’s not being complied with is a completely different aspect,” Justice Mehta remarked during the hearing, noting that while the law mandates safeguards—including videography of the procedure—these are frequently ignored in practice.
Dr. Ganapathy’s petition further alleges instances of “mechanical certification,” claiming that doctors sometimes sign Form 10 (the official brain death certificate) without physically examining the patient. The Court noted a “ring of truth” in these concerns, prompting the call for a scientific re-evaluation.
Modern Technology vs. Clinical Tradition
The AIIMS committee, expected to consist of 3 to 5 specialists from the Department of Neurology, will evaluate whether India should adopt “ancillary tests” to supplement or replace the apnea test.
The proposed alternatives include:
-
Cerebral Angiogram: A diagnostic that visualizes blood flow. If no blood reaches the brain, it provides objective evidence of irreversible cessation of function.
-
Electroencephalogram (EEG): A test that records electrical activity in the brain. A “flat” EEG suggests a lack of neuronal activity.
-
Radionuclide Scanning: Using radioactive tracers to confirm the absence of cerebral blood flow.
While these tests offer digital, verifiable data, the medical community remains divided. Many neurologists argue that brain death is a clinical diagnosis and that the apnea test, when performed correctly, remains the global “gold standard.”
Dr. Manjari Tripathi, Head of Neurology at AIIMS, has previously defended the existing framework, noting that it aligns with international standards and is executed with extreme diligence. Experts also caution that mandating high-tech imaging for every case could be logistically impossible for smaller hospitals and might delay the time-sensitive window for organ retrieval.
Public Health and the Trust Deficit
The implications of this review extend far beyond the courtroom. India’s organ donation rate remains among the lowest in the world, largely due to a lack of awareness and a deep-seated mistrust of the “brain dead” label.
“Brain death” is often a misnomer for the public; it describes a state where the brain has ceased to function, but the heart is kept beating by machines. This allows for beating-heart organ donation, which provides the highest quality organs for recipients. However, any suspicion that the certification process is flawed or rushed can devastate public confidence.
“For the organ donation program to succeed, the public must have absolute certainty that ‘death’ is determined with 100% accuracy and integrity,” says a public health policy expert. “If families feel the process is a mere formality to harvest organs, they will stop consenting.”
Looking Ahead: The AIIMS Mandate
The Supreme Court has asked the AIIMS committee to submit its recommendations in a sealed cover within two months. The committee will specifically investigate:
-
The safety and scientific validity of the apnea test compared to technological alternatives.
-
The practicability of implementing mandatory EEG or angiograms across diverse Indian healthcare settings.
-
Measures to ensure strict compliance with existing laws, such as mandatory videography.
The case is scheduled for its next hearing on July 21, 2026. The findings could lead to a landmark update of the THOTA Rules, potentially introducing stricter, more objective requirements for declaring death in the digital age.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
The Hindu (May 2, 2026). “Supreme Court to examine plea that apnoea test is inconclusive to assess brain death.” [thehindu.com]
